Who invested in Spyre Therapeutics?
Spyre Therapeutics's investors include Perceptive Advisors, Cormorant Asset Management, RTW Investments LLC and Adage Capital Management.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$678Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
From Spyre Therapeutics's own website and the SEC filings it signed: 6 on the team.
On the board, as filediAlison J. LawtonJeffrey W. AlbersLaurie J. StelzerMichael J. HendersonPeter J. HarwinRussell J. CoxTomas J. Kiselak
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Spyre Therapeutics's investors include Perceptive Advisors, Cormorant Asset Management, RTW Investments LLC and Adage Capital Management.
Spyre Therapeutics has raised $678M across 2 rounds since 2025.
Spyre Therapeutics's most recent round was an Undisclosed round of $403M in Apr 2026.
Its most recent round, $403M in Apr 2026, is also its largest on record.
Spyre Therapeutics's first round on record, in Oct 2025, was backed by Perceptive Advisors, Cormorant Asset Management and RTW Investments LLC and 1 others.
Spyre Therapeutics's latest named round is an Undisclosed round, in Apr 2026.
Spyre Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.